Back to search results

AI Mapping for Atrial Fibrillation Ablation Study

This study is comparing two ways to treat Atrial Fibrillation (AF), a condition where your heart beats irregularly. One group will receive a standard treatment called Pulmonary Vein Isolation (PVI). The other group will receive PVI along with a special system called vMap®, which uses artificial intelligence to help plan the procedure. The goal is to see if adding vMap® helps keep you free from AF for 12 months after the procedure. You might be able to join if you are an adult (22 years or older) with persistent or recurrent AF. The study is currently recruiting 423 participants.

Study design
This is a randomized study where participants have a 50/50 chance of receiving either standard PVI or PVI with the vMap® system. It will involve 423 participants.
What's involved
Participants will undergo an ablation procedure, either PVI alone or PVI with the vMap® system.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after the procedure to see if they remain free from AF.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06935591

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Recruiting
NAAges 22+InterventionalTreatment
Vektor Medical
~423 participants
Updated 2026-03-16 on ClinicalTrials.gov
What's tested:Pulmonary Vein IsolationvMap® + Pulmonary Vein Isolation

At a glance

Recruiting sites
11 of 13 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Freedom from AF
Measured over 12 months post procedure

Conditions

Atrial Fibrillation (AF)

Explore related trials

Atrial Fibrillation

NCT06935591

Where you'd take part

This study runs at 13 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Arrhythmia Research Group - St. Bernards

    Jonesboro, Arkansasstudy coordinator listed

    Recruiting

  • Baptist Health Jacksonville

    Jacksonville, Floridastudy coordinator listed

    Recruiting

  • Baptist Health Lexignton

    Lexington, Kentuckystudy coordinator listed

    Recruiting

  • BayCare Health System

    Clearwater, Floridastudy coordinator listed

    Recruiting

  • German Heart Center

    Munich, Germanystudy coordinator listed

    Recruiting

  • Indiana University

    Indianapolis, Indianastudy coordinator listed

    Recruiting

  • OhioHealth

    Columbus, Ohiostudy coordinator listed

    Recruiting

  • Penn Presbyterian

    Philadelphia, Pennsylvaniastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Kayla Rubino
[email protected]
870-935-6729
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Atrial fibrillation type
Atrial characteristics: geometry (normal, left and/or right atrial enlargement), Utah classification, prior ablation modality (e.g., radiofrequency, cryoablation, pulsed field ablation), prior ablation lesion location(s). 4. Subject is ≥ 22 years of age at time of enrollment/consent. 5. Subject is indicated to undergo an ablation procedure at the medical discretion of the Investigator. 6. Subject is able and willing to comply with the protocol requirements, has been informed of the nature of the study,

What this trial measures

  • Freedom from AF12 months post procedure

    The achievement of freedom from AF for subjects on or off antiarrhythmic drug (AAD) therapy at 12 months.